Vernakalant vs propafenone vs flecainide in atrial fibrillation.

Trial Profile

Vernakalant vs propafenone vs flecainide in atrial fibrillation.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 May 2014

At a glance

  • Drugs Vernakalant (Primary) ; Flecainide; Propafenone
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2013 New trial record
    • 23 Sep 2013 Positive results published in the Journal of Atrial Fibrillation, according to a Cardiome media release. Top-line results also reported in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top